No Data
Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Insiders, Who Hold 39% of the Firm Would Be Disappointed by the Recent Pullback
Chengdu Kanghong Pharmaceutical Group H1 Profit Up 32%, Operating Income Climbs 19%; Shares Fall 10%
Chengdu Kanghong Pharmaceutical Group: Summary of Half-Year Report in 2024.
Chengdu Kanghong Pharmaceutical Group: Half-year report for the year 2024.
Chengdu Kanghong Pharmaceutical Group (002773.SZ): Net income in the first half of the year was 0.692 billion yuan, a year-on-year increase of 31.77%.
On August 22, Kanghong Pharmaceutical (002773.SZ) released its semi-annual report, with revenue of 2.294 billion yuan, a year-on-year growth of 19.46%, net income of 0.692 billion yuan, a year-on-year growth of 31.77%, non-GAAP net income of 0.678 billion yuan, a year-on-year growth of 33.10%, and basic earnings per share of 0.75 yuan.
As of August 9, 2024, the number of shareholders of Chengdu Kanghong Pharmaceutical Group (002773.SZ) was 32,065.
Chengdu Kanghong Pharmaceutical Group (002773.SZ) stated on the investor interaction platform on August 12 that as of August 9, 2024, the number of shareholders in the company was 32,065.
Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Shares Fly 25% But Investors Aren't Buying For GrowthNo Data
No Data
